Initial Statement of Beneficial Ownership (Form 3)

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * Koka Durga Prasad 2. Date of Event Requiring Statement (Month/Day/Year) 09/08/2025 3. Issuer Name and Ticker or Trading Symbol Cigna Group [CI] (Last) (First) (Middle) 900 COTTAGE GROVE RD 4. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) EVP, Global CIO 5. If Amendment, Date Original Filed (Month/Day/Year) (Street) BLOOMFIELD, CT 06002 6. Individual or Joint/Group Filing (Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5) Common Stock, $.01 Par Value 4,324 D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	11/05/2022(1)	11/05/2031	Common Stock, $.01 Par Value	638	$218.2525	D
Employee Stock Option (Right to Buy)	03/01/2023(2)	02/23/2032	Common Stock, $.01 Par Value	634	$227.02	D
Employee Stock Option (Right to Buy)	03/01/2024(3)	02/22/2033	Common Stock, $.01 Par Value	842	$294.61	D
Employee Stock Option (Right to Buy)	03/01/2025(4)	02/28/2034	Common Stock, $.01 Par Value	1,137	$336.475	D
Employee Stock Option (Right to Buy)	03/01/2026(5)	02/28/2035	Common Stock, $.01 Par Value	1,359	$305.855	D

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Koka Durga Prasad 900 COTTAGE GROVE RD BLOOMFIELD, CT 06002			EVP, Global CIO

Signatures

Elise Ryan, attorney-in-fact		09/17/2025
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	This option was granted on November 5, 2021. The option vested in three equal annual installments beginning November 5, 2022.
(2)	This option was granted on February 23, 2022. The option vested in three equal annual installments beginning March 1, 2023.
(3)	This option was granted on February 22, 2023 and vests in three equal annual installments. The first two installments became exercisable on March 1, 2024 and March 1, 2025, and the last installment becomes exercisable on March 1, 2026.
(4)	This option was granted on February 22, 2024, and vests in three equal annual installments. The first installment became exercisable on March 1, 2025, and the next two installments become exercisable on March 1, 2026 and March 1, 2027.
(5)	5. This option vests in three equal annual installments beginning March 1, 2026.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.